Pregnancy treating adults ADHD Research and News

Methylphenidate, Atomoxetine Safe to Use in Pregnancy: New Study

Reading now: 332
additudemag.com

January 16, 2025Methylphenidate and atomoxetine use do not increase a pregnant woman’s risk for miscarriage or congenital anomalies in the fetus, finds a new systematic review and meta-analysis published in JAMA Network Open.1The review included 10 studies involving 16.5 million pregnant women from 6 countries.

It is the first study to compare pregnant women with ADHD who took methylphenidate or atomoxetine with pregnant women with ADHD who did not take these medications, as well as with pregnant women who did not have ADHD or take these medications.The study, which helps to fill in the gaps of a still-evolving research landscape, has critical implications for millions of women of reproductive age.

Medications for ADHD including atomoxetine and methylphenidate are classified by the FDA as “pregnancy category C,” indicating a lack of controlled studies.

As a result, no definitive guidelines yet exist for prescribers, though recent research has demonstrated that many ADHD medications are safe for use in pregnancy.

Read more on additudemag.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA